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A DILEUCINE SIGNAL SITUATED IN THE C-TERMINAL TAIL OF THE LYSOSOMAL MEMBRANE 
PROTEIN P40 IS RESPONSIBLE FOR ITS TARGETING TO LYSOSOMES 
 
Marielle BOONEN, Roberta REZENDE de CASTRO, Gaëlle CUVELIER, Isabelle HAMER, Michel 
JADOT 
URΦM, Laboratoire de Chimie Physiologique, FUNDP, B-5000 Namur, Belgium 
 
Address correspondence to M. Jadot, URΦM, Laboratoire de Chimie Physiologique, Facultés 
Universitaires Notre-Dame de la Paix, 61, rue de Bruxelles, B-5000 Namur, Belgium  
Tel. ++32 (0)81724262 ; Fax. ++32 (0)81724272 ; E-mail: michel.jadot@fundp.ac.be 
Running Title: Lysosomal targeting of p40  
Keywords: Lysosome, membrane, p40, dileucine signal, trafficking 
 
ABSTRACT 
 
Transport of newly synthesised lysosomal membrane proteins from the TGN to the lysosomes is due 
to the presence of specific signals in their cytoplasmic domains that are recognised by cytosolic 
adaptors. p40, a hypothetical transporter of 372 amino acids localised in the lysosomal membrane, 
contains four putative lysosomal sorting motifs in its sequence: three of the YXXφ–type (Y6QLF, 
Y106VAL, Y333NGL) and one of the [D/E]XXXL[L/I]-type (EQERL360L361). To test the implication of 
these motifs in the biosynthetic transport of p40, we replaced the most critical residues of these 
consensus sequences, the tyrosine or the leucine-leucine pair, by alanine or alanine-valine, 
respectively. We analysed the subcellular localisation of the mutated p40 proteins in transfected HeLa 
cells by confocal microscopy and by biochemical approaches (subcellular fractionation on self-
forming Percoll density gradients and cell surface biotinylation). Our results show that p40 is mis-
targeted to the plasma membrane when its dileucine motif is disrupted. No role of the tyrosine motifs 
could be put forward. Taken together, our results provide evidence that the sorting of p40 from the 
TGN to the lysosomes is directed by the dileucine EQERL360L361 motif situated in its C-terminal tail.  
 
Abbreviations used: TGN, trans-Golgi Network; LAMP-1, Lysosome-associated membrane protein; 
LIMP-II, Lysosomal integral membrane protein; LAP, Lysosomal Acid Phosphatase; AP, Adaptor 
Protein; HA, Hemagglutinin; GFP, Green Fluorescent Protein; ER, Endoplasmic Reticulum; TR-
dextran, Texas Red-Dextran 
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INTRODUCTION 
 
The vesicular transport of newly synthesised lysosomal membrane proteins from the trans-
Golgi network (TGN) to the lysosomes can follow two routes. The precursor proteins can either be 
sent directly toward the endo/lysosomal system, or be first targeted to the plasma membrane where 
they can be addressed to the lysosomes by endocytosis. The incorporation of the transmembrane 
proteins into coated budding vesicles destined to lysosomes is due to the presence of specific signals in 
their cytosolic domains. These signals are short amino acid sequences, generally of the YXXφ-type 
(tyrosine-based signal) where φ is a bulky hydrophobic amino acid, or [D/E]XXXL[L/I]-type 
(dileucine-based signal) [1]. The tyrosine and the leucine-leucine (or leucine/isoleucine) residues are 
critical for the sorting step, their mutation severely impairing the targeting of the membrane proteins to 
lysosomes. These motifs are often situated within cytosolic regions, near the carboxy-terminal end of 
the transmembrane protein like in LAMP-1, LIMP-II or LAP [2-4], or near its amino-terminal end, 
like in sialin [5]. 
The recognition of the lysosomal sorting signals by cytosolic adaptor molecules allows the 
selection and the concentration of the membrane proteins into budding sites at the TGN or plasma 
membrane. The most extensively investigated adaptors are the heterotetrameric complexes AP-1, AP-
2, AP-3 and AP-4, each of them composed by one small (σ1- σ4), one medium (µ1-µ4) and two large 
subunits (β1- β4 and γ for AP-1, α for AP-2, δ for AP-3 or ε for AP-4) [6, 7]. It is well established that 
tyrosine-based motifs are recognised by the µ subunits [8]. By contrast, the binding site for dileucine-
based motif is still controversial. It has been reported that this motif could bind to the β subunits of 
AP-1 and AP-2 [9, 10] and the µ subunit of AP1, AP-2 and AP-3 [11-13]. More recent studies have 
revealed stronger interactions between the [D/E]XXXL[L/I] motif and specific combinations of two 
subunits from the AP-1 and AP-3 complexes (γ/σ1 and δ/σ3 hemicomplexes) [14] or from the AP-1 
and AP-2 complexes (γ/σ1 and α/σ2 hemicomplexes) [15]. Mammalian AP-1 and AP-2 are mainly 
associated with the TGN and the plasma membrane, respectively, where they bind cargo molecules 
destined to the endosomal system and promote the vesicle coat assembly [16, 17]. The presence of 
AP-1 is also observed at endosomal sites where it plays a role in the retrograde transport from 
endosomes to the TGN [18]. AP-3 is localised on endosomes and on the TGN, where it has been 
implicated in the sorting of lysosomal proteins [19-22], as well as in the biogenesis of “lysosome-
related” organelles such as melanosomes, some synaptic vesicles, secretion granules or platelet dense 
granules [23-27]. AP-4 has been mainly detected in clathrin-coated and -uncoated areas of the TGN, in 
endosomes and in transport vesicles [28, 29], and has been shown to play a role in a direct intracellular 
trafficking route to lysosomes and in the basolateral membrane sorting in MDCK cells [30, 31]. 
The lysosomal membrane protein we are interested in, is a predicted multispanning protein of 
372 amino acids named p40. This protein has been identified by mass spectrometry analysis of the 
most hydrophobic proteins extracted from a rat liver lysosomal membrane preparation [32]. Its 
association with the lysosomes has been previously validated by subcellular fractionation performed 
on mouse liver and by fluorescence microscopic examination, performed on transiently transfected 
cells [32]. p40 contains four putative lysosomal sorting motifs: Y6QLF, Y106VAL, Y333NGL and 
EQERL360L361, respectively. To determine their potential role in the biosynthetic transport of p40 to the 
lysosomal membrane, we have disrupted each of these putative signals by site-directed mutagenesis. 
The critical tyrosine residues have been replaced by an alanine, and the two leucine residues (360-361) 
by an alanine and a valine. The impact of these mutations on the localisation of p40 has been analysed 
by confocal fluorescence microscopy and biochemically, using subcellular fractionation on self-
forming Percoll density gradients and cell surface biotinylation. Our results demonstrate that the 
dileucine motif situated near the C-terminal end of p40 is an essential determinant for the targeting of 
this protein to the lysosomal membrane. 
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MATERIAL AND METHODS 
 
Mutation of the potential lysosomal targeting signals 
 
p40-GFP and GFP-p40 proteins were engineered as described in Boonen et al. [32]. Mutations of 
putative sorting motifs were introduced in wild-type p40-GFP by overlap extension using PCR. The 
tyrosine residues of the Y6QLF, Y106VAL and Y333NGL motifs were replaced by alanine residues 
(Y6A, Y106A and Y333A), whereas the two leucine residues in the C-terminal EQERL360L361 motif 
were substituted by an alanine and a valine, respectively (LL360AV). The primers (sense and 
antisense) bearing the mutations were the following: Y6A-F (5’-GT AAG GCC CAG TTG TTC CTG 
GCC G-3’); Y6A-R (5’-CAA CTG GGC CTT AGT CCA GGC CAT A-3’); Y106A-F (5’-C ATG 
GCC GTG GCC CTG AAC ATG ACC A-3’); Y106A-R (5’-C CAC GGC CAT GAT GCT GGT 
CCC AGT C-3’); Y333A-F (5’-GCC CTC GCC AAT GGG CTG CAC CGA CCA CT-3’); Y333A-R 
(5’-CCC ATT GGC GAG GGC GGT GCC CAT AAG G-3’); LL360AV-F (5’-A GAG AGA GCG 
GTA GGT GAC AGT CGG ACT CCC-3’) and LL360AV-R (5’-CT GTC ACC TAC CGC TCT CTC 
TTG CTC TCC C-3’). Final mutated PCR products were cloned into pCMV-Sport6_p40-GFP by 
EcoRI/BamHI. 
To introduce the dileucine mutation into wild-type p40 (without GFP), a linker containing an EcoRI 
restriction site and a stop codon (5’-GATCCCTGAGAATTCTCAGG-3’) was generated and inserted 
at the BamHI restriction site situated between p40 and the GFP in p40-LL360AV-GFP. The p40 
fragment, bearing the dileucine mutation, was then excised by EcoRI and cloned in place of wild-type 
p40 in pCMV-Sport6_p40 to obtain pCMV-Sport6_p40-LL360AV. This construct was used to 
generate GFP-p40 bearing the dileucine substitution (LL360AV). The p40-LL360AV fragment was 
excised by BstEII and MluI and inserted into GFP-p40 via the same restriction enzymes.   
An hemagglutinin (HA) tag was introduced at the C-terminal end of p40, by excision of the GFP 
moiety of p40-GFP with BamHI and NotI and its replacement by a linker containing the HA-tag, a 
stop codon, and BamHI/NotI restriction sites. The linker was formed by the hybridisation of the two 
following primers: 5’- GAT CCG TAC CCA TAC GAC GTC CCA GAC TAC GCT TGA T -3’ and 
5’- C TAG ATC AAG CGT AGT CTG GGA CGT CGT ATG GGT ACG -3’). The fusion of the HA-
tag at the C-terminal end of the dileucine mutant of p40 was performed by replacing the wild-type p40 
portion of p40-HA by the same dileucine mutated portion excised from p40-LL360AV-GFP. This was 
performed by enzymatic restriction with EcoRI and BamHI.  
 
Cell culture and transient transfection 
 
HeLa cells were cultured at 37°C in a humidified atmosphere with 5% CO2 in glucose-rich Dulbecco’s 
modified Eagle medium (DMEM) (LONZA, Verviers, Belgium) containing 10% fetal calf serum 
(Greiner Bio-one), 100 U/ml penicillin and 100 µg/ml streptomycin. Transient transfections of 
plasmids were performed with the FuGene transfection reagent (Roche Diagnostics, Vilvoorde, 
Belgium) according to the manufacturer’s instructions.  
 
Fluorescence labelling 
 
Forty-eight hours post-transfection with GFP contructs, HeLa cells were fixed with methanol/acetone 
(80:20) for 20 min at -20°C and permeabilised with 0.05% saponin for 10 min at room temperature. 
After blocking of the non-specific binding sites for 10 min at room temperature with 1% BSA in PBS, 
cells were incubated for 2 h with a mouse anti-human LAMP-1 monoclonal antibody (H4A3, 
Developmental Studies of Hybridoma Bank, Iowa, IA, USA), followed by an Alexa 568-conjugated 
goat anti-mouse antibody (Molecular Probes, Invitrogen, Merelbeke, Belgium) for 50 min. Coverslips 
were mounted in Mowiol and fluorescence was observed with a LeicaTM confocal microscope.  
Similar protocol was applied in cells transfected with p40 or p40-HA constructs, except that p40 
proteins were detected with a specific polyclonal rabbit antibody directed against the last 15 amino 
acids of p40 (ERLLGDSRTPINEAS) or with an anti-HA polyclonal rabbit antibody (Sigma-Aldrich, 
Saint-Louis, MO, USA), respectively. Primary antibodies were detected with an Alexa 488-conjugated 
goat anti-rabbit antibody (Molecular Probes, Invitrogen, Merelbeke, Belgium).  
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The labelling with Texas Red-dextran of HeLa cells transfected with p40-GFP constructs was 
performed as previously described [32]. Briefly, cells were incubated for 30 min in serum-free DMEM 
at 37°C and then for 6 h in DMEM with serum containing 2 mg/ml of Texas Red-dextran (10,000 
MW, Molecular Probes, Invitrogen, Merelbeke, Belgium). After 4 washes with HBSS, cells were 
incubated for 2 h in dextran-free medium, washed again, fixed with ice-cold 4% paraformaldehyde 
and mounted in Mowiol (Calbiochem).  
 
Inhibition of AP-2-dependent endocytosis 
 
For the study on the intracellular trafficking of p40, HeLa cells were transiently co-transfected with 
either the wild-type or the dileucine mutated p40 tagged with the HA epitope along with a dominant 
negative construct of Eps15 (GFP-E∆95/295) (kindly provided by Dr. A. Benmerah). Twenty-four 
hours post-transfection, cells were washed, fixed with 4% paraformaldehyde and permeabilised in 1% 
Triton X-100. The inhibition of the AP-2-dependent endocytosis was checked by incubating HeLa 
cells transiently transfected with the GFP-E∆95/295 construct alone, during 15 min with 50 µg/ml of 
Alexa 568-conjugated human transferrin (Molecular Probes, Invitrogen, Merelbeke, Belgium). Cells 
were then washed three times in cold PBS and fixed in 4% paraformaldehyde. Blocking and labelling 
were processed as described above. 
 
Cell surface biotinylation  
 
Transfected HeLa cells were washed twice with ice-cold PBS and five times with PBS supplemented 
with 0.7 mM CaCl2 and 0.25 mM MgSO4 (PBS++, pH 8). Cell surface proteins were labelled by 
incubation with 1 mg/ml of sulfo-NHS-SS-Biotin in PBS++ (Pierce, Rockford, IL, USA) for 45 min on 
ice. Biotinylation was stopped by washing 5 times with ice-cold 50 mM glycine/PBS++ and cells were 
lysed with RIPA buffer (50 mM Tris-HCl, pH 7.4, 120 mM NaCl, 1% Triton X-100, 0.1% SDS, 1% 
deoxycholate) containing protease inhibitors (Complete, Mini, Protease inhibitor cocktail tablets, 
Roche, Mannheim, Germany). Biotinylated proteins were precipitated with streptavidine-agarose 
beads (Pierce, Rockford, IL, USA) by centrifugation at 4°C for 5 min at 5,000 g in a bench top 
centrifuge and then eluted by incubation for 40 min at room temperature in Laemmli’s buffer 
containing 200 mM of fresh DTT. One tenth of the supernatant obtained after centrifugation, 
containing proteins unbound to streptavidine beads, and proteins eluted from the beads (bound) were 
loaded onto a 12% SDS-PAGE. Proteins were electrotransferred onto low fluorescence PVDF 
membranes (Amersham Hybond LFP, GE Healthcare, Buckinghamshire, United Kingdom) which 
were blocked for 10 min with 10% skimmed milk in 0.1% Tween/PBS. Detection of p40, p40-HA or 
GFP-tagged proteins was performed with a rabbit antiserum raised against the 15 C-terminal amino 
acids of mouse p40, with a rabbit polyclonal antibody anti-HA (Sigma, Saint-Louis, MO, USA) or 
with a rabbit polyclonal antibody directed against GFP (Santa Cruz Biotechnology, Huissen, 
Netherlands), respectively. Membranes were then incubated for 1 h with an Alexa 488-conjugated 
goat anti-rabbit antibody (Molecular Probes, Invitrogen, Merelbeke, Belgium). Signal detection was 
performed using the TyphoonTM fluorescence scanning system (GE Healthcare, Buckinghamshire, 
United Kingdom) and intensities were quantified with the ImageQuantTM analysis software (GE 
Healthcare, Buckinghamshire, United Kingdom). 
 
Self-forming Percoll density gradient 
 
Confluent cells grown in three 100-mm Petri dishes were rinsed three times with PBS, then twice with 
ice-cold 0.25 M sucrose. Cells were scraped in 1 mL of ice-cold 0.25M sucrose and homogenised by 
10 passages through a 25-gauge needle mounted on a 5 ml syringe. Cell homogenate was subjected to 
a centrifugation at 1,500 rpm for 10 min at 4°C in an International Centrifuge PR-J (International 
Equipment Co.). The pellet was suspended in 2 ml of ice-cold 0.25 M sucrose, disrupted by 10 
passages through a 25-gauge needle and submitted to another centrifugation at 1,500 rpm for 10 min at 
4°C. This second pellet corresponded to the nuclear fraction (N). The 4-5 mL post-nuclear supernatant 
was then centrifuged at 35,000 rpm for 40 min in a Beckman 50Ti rotor (4°C) in order to sediment the 
membrane compartments (MLP fraction). The MLP pellet was resuspended in 1 mL of ice-cold 
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sucrose and mixed with 8 ml of an 18% Percoll solution (18% v/v Percoll, 0.25 M sucrose, 2 mM 
EDTA, 10 mM Tris-HCl, pH 7.4). The solution (9 ml) was then layered onto 1 ml of a 2.2 M sucrose 
cushion and centrifuged for 1 h at 20,000 gav in a Beckman 50Ti rotor at 4°C. Seven fractions were 
collected from the top to the bottom of the gradient. The β-galactosidase and alkaline 
phosphodiesterase enzymatic activities were assayed in each fraction as described previously [33, 34]. 
The distributions of the p40/p40-GFP and LAMP-1 proteins were analysed by Western blotting as 
described above, except that the signals detection was performed using the Western Lightning 
Chemiluminescence Reagent Plus (Perkin Elmer Life Science, Zaventem, Belgium). 
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RESULTS  
 
Mutation of the putative lysosomal sorting motifs of p40: effect on its localisation in transfected 
cells 
 
p40 contains four putative lysosomal sorting motifs: three of the tyrosine-type (Y6QLF, 
Y106VAL and Y333NGL), and one of the dileucine-type (EQERL360L361) (Figure 1). Based on 
computational topology prediction models, it seems unlikely that the tyrosine motif at position 106 
acts as a sorting signal since it appears to be localised in one of the 8-10 predicted transmembrane 
regions. Nevertheless, we analysed the role of each motif in the biosynthetic transport of p40 to 
lysosomes. We first engineered a GFP chimaeric protein in which the GFP was fused C-terminally to 
the mouse p40 protein (p40-GFP). Then, we mutated each putative signal separately in the p40-GFP 
protein. We replaced the critical tyrosine residues by alanine (mutations Y6A, Y106A or Y333A) and 
the two leucine residues of the EQERL360L361 sequence by an alanine and a valine, respectively 
(mutation LL360AV) (Figure 1). The wild-type and mutated p40-GFP proteins were transfected in 
HeLa cells and their subcellular localisation was observed 48 h post-transfection by confocal 
fluorescence microscopy. The late endosomal/lysosomal compartments were localised by 
immunofluorescence, using an antibody directed against LAMP-1 (Figure 2A). As previously shown 
[32], wild-type p40-GFP transfected in HeLa cells displayed a punctuated labelling throughout the 
cytoplasm with a predominance in the perinuclear region, and extensively colocalised with LAMP-1 
(Figure 2A). No signal was detected at the plasma membrane. A similar distribution was observed for 
p40 (without the GFP-tag), and for p40 proteins with a GFP-tag fused N-terminally (GFP-p40) or a 
HA-tag fused C-terminally (p40-HA) (Figure 2A). These results suggest that the addition of a GFP or 
a HA-tag does not interfere with the lysosomal localisation of the protein.  
The p40-GFP proteins mutated at one tyrosine motif (Y6A, Y106A or Y333A) exhibited the 
same distribution as that of wild-type p40-GFP, and thus extensively colocalised with LAMP-1 
(Figure 2B). In contrast, substitution of the two leucine residues of the C-terminal EQERL360L361 motif 
induced the targeting of p40-GFP proteins to the plasma membrane (Figure 3A). Similar results were 
obtained after the introduction of the dileucine mutation in wild-type p40, in GFP-p40 or in p40-HA 
chimaeric proteins (Figure 3A). The partial diversion of the p40 dileucine mutant to the cell surface 
was also observed after transfection in BHK21 cells (Figure 1S, Supplementary data). Nevertheless, 
irrespective of the construct, a significant portion of the LL360AV mutated proteins still generated an 
intracellular signal and colocalised with LAMP-1 both in HeLa cells and BHK21 cells (Figures 3A 
and 1S).  
Cells transfected with p40-GFP or its dileucine mutated form were incubated with Texas Red-dextran 
(Figure 3B). This molecule enters the cells by fluid-phase endocytosis and is transported through the 
early and late endosomes to the lysosomes where it accumulates owing to its resistance to hydrolysis. 
Incubation of the transfected cells with Texas Red-dextran for 6 h followed by a 2 h-chase in dextran-
free medium to allow its accumulation in late endocytic compartments, revealed an extensive 
colocalisation between the fluorescent probe and wild-type p40-GFP (Figure 3B). The intracellular 
signal observed for the dileucine mutant of p40-GFP also extensively colocalised with the fluorescent 
probe (Figure 3B), confirming its partial localisation in a compartment of the endocytic pathway.  
The observation of a dual intracellular/plasma membrane localisation for the dileucine mutant 
raises the possibility of another functional sorting determinant which could mediate the targeting of 
p40 to lysosomes in the absence of the EQERL360L361 motif. In order to test the putative contribution of 
the tyrosine motifs to the sorting of p40 when the dileucine signal is disrupted, these motifs were 
mutated in the LL360AV-mutated p40-GFP construct. All p40-GFP proteins bearing the LL360AV 
substitution, in addition to the mutation of one tyrosine motif (double mutants) or the three tyrosine 
motifs together (quadruple mutant), were partly associated with the plasma membrane (Figure 4). 
However, as observed with the single dileucine mutated proteins, a subpopulation of each mutant 
protein remained associated with a LAMP-1 positive intracellular compartment (Figure 4), suggesting 
that the tyrosine mutations had no additional effect on the mistargeting of p40 proteins to the plasma 
membrane, compared to the single LL360AV mutation.  
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Distribution of wild-type and mutated p40 proteins (LL360AV) on Percoll density gradients 
 
We tested the delivery of wild-type p40 and p40-GFP, with and without the LL360AV 
substitution, to dense lysosomes as identified by centrifugation on a self-forming Percoll density 
gradient. MLP fractions (the high speed pellets of post-nuclear supernatants) were submitted to 
centrifugation on iso-osmotic self-forming Percoll density gradients. Measurements of β-galactosidase 
and alkaline phosphodiesterase activities were performed in the collected fractions, in order to localise 
the lysosomes and the plasma membrane, respectively. As expected, the majority of the β-
galactosidase activity was recovered in the highest density fractions, while the plasma membrane 
marker was mainly associated with more buoyant fractions (Figure 5). Detection of p40 and p40-GFP 
proteins by Western blotting revealed their presence in all fractions with a predominance in the light 
density fractions (~1.052-1.057 g/mL) and in the highest density fraction (~1.16 g/mL). This pattern 
was similar to the bimodal distribution profile of the late endosomal/lysosomal marker LAMP-1. By 
contrast, the dileucine mutants (LL360AV) with and without GFP, were not detected in the dense 
lysosomes containing fractions. This shift in p40 distribution observed on Percoll density gradients 
after substitutions of the two leucine residues at positions 360-361, confirms the crucial role of the 
dileucine motif in the targeting of p40 to lysosomes. 
 
Plasma membrane association of the wild-type and mutated p40 proteins 
 
 The relative abundance of the wild-type and mutated proteins at the plasma membrane was 
estimated by cell surface biotinylation. Transfected cells were incubated with sulfo-NHS-SS-Biotin for 
45 min on ice, lysed and incubated with streptavidine-agarose beads in order to separate the 
biotinylated (Bound) from the non-biotinylated (Unbound) proteins. The bound proteins, eluted from 
the beads, and one tenth of the unbound proteins were resolved by SDS-PAGE. The proportion of each 
p40 construct recovered in the Bound and Unbound samples was estimated by Western blotting using 
the fluorescence based ECL PlexTM system (GE Healthcare, Buckinghamshire, UK). Detection of the 
intracellular EEA1 (Early Endosome Antigen 1) protein was used as a control of membrane integrity. 
As shown in figure 6A, wild-type p40-GFP and the corresponding proteins mutated in one of the 
tyrosine motif (Y6A, Y106A or Y333A) were very poorly biotinylated (<5%), supporting their 
intracellular localisation. The mutation of the dileucine signal (LL360AV) in p40-GFP induced the 
appearance of 21 ± 3% (n=6) of the molecules in the biotinylated fraction attesting of their exposure to 
the extracellular medium. Mutation of the tyrosine motifs at positions 6, 106, or 333, together with the 
dileucine signal (double and quadruple mutants) did not increase the percentage of proteins associated 
with the bound fraction, providing further evidence that the tyrosine motif mutations have little or no 
additional impact on the mistargeting of the dileucine mutant to the plasma membrane.  
Wild-type p40, the C-terminally HA- and N-terminally GFP- tagged p40 constructs yielded 
very low percentages of proteins in their biotinylated form (7 ± 2%, 2 ± 0% and 3 ± 1%, respectively, 
with n ≥ 3) (Figure 6B). When the dileucine mutation was introduced in p40-HA and GFP-p40, 24 ± 
4% (n=3) and 22 ± 7% (n=3) of p40 proteins were detected among the biotinylated proteins, 
respectively (Figure 6B), which was not different from the values obtained with the mutated p40-GFP 
protein (21 ± 3%; n=6) (Figure 6A). By contrast, in the absence of any tag, 49 ± 11% (n=7) of 
dileucine mutants were biotinylated (Figure 6B), showing that the presence of a GFP or a HA-tag has 
an effect on the association of the mutated protein with the cell surface.  
 
Intracellular trafficking of the wild-type and mutated p40 proteins 
 
In steady-state, only a low level of wild-type-p40 appears at the cell surface. We asked 
whether p40 molecules passed through the plasma membrane on their way to the endolysosomal 
compartments, as described for other lysosomal membrane proteins, including the LAMPs [35]. To 
achieve this goal, we overexpressed p40 in HeLa cells together with a dominant negative form of 
Eps15, which is known to inhibit AP2-dependent endocytosis by sequestering AP-2 in the cytosol 
[36]. First, we checked the efficiency of this EH-deleted form of Eps15 tagged with GFP, to block AP-
2-dependent endocytosis by measuring the uptake of an Alexa 568–conjugated transferrin, a well 
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known marker of clathrin-mediated endocytosis [36, 37]. We observed that the uptake of transferrin 
was effectively inhibited although to very different extents in individual cells. The most prominent 
inhibition of transferrin uptake was observed in cells expressing a high level of GFP-Eps15 EΔ95/295 
(Figure 7A). Then, we analysed the distribution of wild-type p40 in cotransfected cells expressing high 
levels of GFP-Eps15 EΔ95/295. As shown in Figure 7, the immunofluorescent staining of p40 
remained in the perinuclear area as in cells expressing p40 alone (Figure 2A), and did never appear at 
the cell surface (Figure 7B). This result supports the idea that wild-type-p40 proteins gain access to the 
endolysosomal compartment without passing through the plasma membrane. The same experiment 
was carried out with the dileucine mutated p40 proteins and showed that the staining was present in an 
intracellular compartment but also at the cell surface (Figure 7C), as described above for the cells not 
transfected with the dominant negative form of Eps15. 
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DISCUSSION 
 
Our study on the implication of the four putative lysosomal sorting motifs of p40 (Y6QLF, 
Y106VAL, Y333NGL, EQERL360L361) in its biosynthetic transport to the lysosomes has revealed a key 
role of the C-terminal EQERL360L361 motif. Indeed, replacement of the leucine pair by other amino 
acids (LL360AV) induced a mistargeting of the protein to the plasma membrane, as judged by 
confocal fluorescence microscopy and by cell surface biotinylation. Using this method, it appeared 
that, in steady-state, up to 49 % of the untagged dileucine mutants were detected at the cell surface. 
Considering that a significant portion of dileucine mutated p40 proteins still colocalised with LAMP-1 
and with the fluid-phase endocytosis tracer Texas Red-dextran after a 2h-chase period, we searched 
for another functional sorting signal in p40 sequence which could act in combination with the 
dileucine motif at the same or another step in the p40 transport towards lysosomes. With this in mind, 
we mutated the other putative targeting motifs found in p40 (Y6QLF, Y106VAL, Y333NGL) together 
with the dileucine signal mutation. No additional impact on the mis-targeting of p40 to the plasma 
membrane was observed as compared to the single dileucine mutant, suggesting that the tyrosine 
motifs would not be implicated in p40 targeting to lysosomes. In the case of LAMP-1, it was shown 
that 95 % of newly-synthesised LAMP-1 proteins mutated in their tyrosine-based sorting signal were 
expressed at the cell surface within 30 min after pulse labelling, suggesting that the tyrosine motif was 
the only lysosomal sorting signal, despite the presence of only 39 % of tyrosine-mutated proteins at 
the cell surface in steady-state [38]. For practical reasons, probably linked to the hydrophobic nature 
of p40, we failed to determine the percentage of newly synthesised p40 expressed at the cell surface. 
However, our results clearly demonstrate that, unlike the tyrosine motifs, the EQERL360L361 motif 
plays a crucial role in the lysosomal sorting of p40. In the future, it should be worthwhile to evaluate 
whether some of the numerous transmembrane domains of p40 contribute or not to its targeting and 
delivery to lysosomes, as it has been described for several integral membrane proteins [39, 40]. The 
lower percentage of the GFP- and HA-tagged mutated p40 proteins at the plasma membrane (21-24 
%) could be the consequence of a less efficient biosynthetic transport. Alternatively, the possible 
misfolding of the dileucine mutants fused to HA or GFP tags could trigger their ubiquitinylation and 
their sorting from the TGN or from the plasma membrane to the endosomal compartments [41-42]. 
This process could result in a lower cell surface to intracellular ratio as compared to untagged proteins. 
Membrane proteins can be targeted to the endo/lysosomes either directly from the TGN or 
indirectly, passing first by the plasma membrane before being directed toward lysosomes along the 
endocytic pathway. The biosynthetic transport of the lysosomal acid phosphatase (LAP) provides an 
example of indirect traffic. Indeed, its precursor cycles several times between early endosomes and the 
plasma membrane before reaching lysosomes [43]. Trafficking through a direct pathway has been 
described for lysosomal membrane proteins such as LIMP-II, GLUT-8, mucolipin 1 and LAMP-1 [20, 
38, 44-48]. Nevertheless, it has recently been suggested that a significant portion of LAMP-1 and 
GLUT-8 is also transported by an indirect pathway since the knock-down of the plasma membrane 
adaptor AP-2 in HeLa cells by siRNA has led to a substantial accumulation of these proteins at the cell 
surface [10, 35]. In contrast, the sorting of mucolipin 1 and LIMP-II to lysosomes has been attributed 
to AP-1 or AP-1 and AP-3, respectively, supporting the idea of their trafficking by an intracellular 
(direct) route [20, 46, 47]. Our data lend support to a direct transport of wild-type p40 from the TGN 
to the lysosomes. Indeed, the coexpression of wild-type p40-HA and a dominant negative form of 
Eps15, known to inhibit clathrin-mediated endocytosis by interacting with AP-2 [36], did not result in 
the appearance of a detectable amount of p40 proteins at the plasma membrane. Therefore, it seems 
likely that newly-synthesised wild-type p40 molecules reach the endosomal compartment primarily by 
the direct pathway following the interactions of the dileucine motif with either AP-1 or AP-3-adaptor 
complexes. The GEQERLL sequence from p40 can potentially be recognized by each of them by 
interactions with isolated subunits [9-13] but most likely with γ/σ1 or δ/σ3 hemicomplexes [14, 15]. 
However, it does not fulfil the criteria described for optimal recognition by AP-3, i.e. the presence of a 
proline residue at position -1, a positively charged amino acid at position -3 and acidic residues at 
positions -4 and -5 from the first leucine [49]. Nevertheless, like p40, the yeast acid lysosomal 
phosphatase which is known to interact with AP-3, contains an arginine residue at position -1 [1, 49]. 
In addition, it seems that the proline residue of ERAPLI motif from LIMP-II is dispensable for the 
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interaction with the δ-σ3A, and δ-σ3B hemicomplexes [14]. Therefore, both AP complexes could a 
priori recognize the dileucine motif of p40.  
The observation of a dual localisation of p40-LL360AV at the cell surface and intracellularly, 
where it co-localises with LAMP-1 could give rise to several interpretations. Part of the intracellular 
signal could represent molecules transiting along with LAMP-1 in biosynthetic compartments. 
Nevertheless, the extensive co-localisation of the dileucine mutant with endocytosed Texas red-
dextran after a 2h-chase seems rather to indicate that the bulk of the mutated proteins present inside 
the cells resides in organelles of the endocytic pathway. The presence of p40-LL360AV in late 
endosomal compartments could be the consequence of its impaired binding to AP-1 and/or AP-3 
adaptor complexes at the TGN, resulting in its diversion to the plasma membrane by default [1, 20, 46, 
49-51]. Once at the cell surface, due to the absence of a functional dileucine motif, p40-LL360AV 
would be slowly internalised by a clathrin-dependent or independent pathway [37, 38, 50]. On the 
other hand, taking into account the partial localisation of the dileucine mutant in endolysosomal 
structures, and its exclusion from dense lysosomes as shown on Percoll density gradients, we cannot 
rule out the possibility that the dileucine signal would be involved in trafficking of the protein from 
late endosomes to dense lysosomes. It is commonly admitted that transport between these 
compartments occurs by default pathway but the existence of a signal-mediated pathway has already 
been proposed to explain the accumulation of a mutant form of LAMP-1 in a prelysosomal 
compartment [52]. Finally, we cannot rule out the possibility that the p40 dileucine mutant was not 
detected in the densest fractions of the Percoll gradient because it is more prone to lysosomal 
degradation than the wild-type p40. Disruption of the different AP complexes by specific siRNA 
would be required to clarify the intracellular trafficking of p40-LL360AV. 
As previously mentioned, the elevated number of predicted transmembrane domains of p40 
and the similarity of part of its sequence with Golgi nucleotide-sugar transporters raise the issue of a 
putative transport activity of p40 in the lysosomal membrane [32]. Small molecular weight molecules 
produced by the intralysosomal hydrolysis are transferred from the lumen of the organelle to the 
cytosol by membrane transporters. To date, only few transporters have been identified in lysosomes 
although transport activities have been described or suggested for a large number of molecules [53-
56]. Among the most extensively characterised lysosomal transporters are those in charge of the 
translocation of cystine (cystinosin) and of sialic acid (sialin), whose deficiency leads to lysosomal 
storage disorders [57-59]. The discovery of the sorting determinants of these membrane proteins has 
been of particular interest in the study of their transport activities. Indeed, expression of sialin and 
cystinosin at the plasma membrane, induced by the mutations of their sorting signals, has permitted 
the design of efficient transport assays [5, 60]. The results of our study, demonstrating the role of the 
p40 EQERL360L361 sequence in its biosynthetic routing could therefore represent a valuable step toward 
the implementation of similar methods in an attempt to unravel the function of this protein. 
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FIGURES LEGENDS 
 
Figure 1. Mutation of the putative sorting motifs of p40. p40 is a protein of 372 amino acids 
containing 4 potential lysosomal membrane targeting signals. Three are of the YXXφ−type (Y6QLF, 
Y106VAL, Y333NGL) and one of the dileucine-type (EQERL360L361). Mutational analysis of these motifs 
was performed as described in Material and Methods. Tyrosine residues at positions 6, 106 or 333 
were replaced by alanine. The two leucine residues situated 11 and 12 residues upstream from the C-
terminal end (L360L361) were replaced by an alanine and a valine, respectively.  
 
Figure 2. Role of the tyrosine motifs in the subcellular sorting of p40. A. HeLa cells transiently 
transfected with p40 proteins (p40, p40-GFP, p40-HA or GFP-p40) were fixed 48h post-transfection, 
permeabilised, and incubated with an anti-LAMP-1 antibody followed by an Alexa 568-conjugated 
goat anti-mouse secondary antibody (red). Cells transfected with wild-type p40 were incubated with a 
polyclonal rabbit antibody raised against the last 15 amino acids of the protein, followed by an Alexa 
488-conjugated anti-rabbit antibody (green). Similarly, HA-fused proteins were detected with an anti-
HA specific polyclonal rabbit antibody followed by the Alexa 488-conjugated anti-rabbit antibody 
(green). The fluorescent signals of the GFP and of secondary antibodies were observed by confocal 
fluorescence microscopy. B. HeLa cells transfected with p40-GFP constructs bearing the mutation of 
one tyrosine motif (Y6A, Y106A or Y333A) were subjected to a LAMP-1 detection as described in A. 
 
Figure 3. Intracellular distribution of the p40 proteins mutated in the C-terminal dileucine motif. A. 
HeLa cells were transiently transfected with p40 or p40 fusion proteins (p40-GFP, GFP-p40 or p40-
HA) in which the two leucine residues (L360L361) were replaced by an alanine and a valine, 
respectively. 48h post-transfection, cells were fixed and LAMP-1, p40 and p40-HA were detected by 
confocal microscopy with specific antibodies as described in figure 2. B. 48 h post-transfection, HeLa 
cells expressing p40-GFP or p40-LL360AV-GFP (dileucine mutant) were pulsed for 6 hours with 2 
mg/ml Texas Red-dextran, followed by 2 h chase in a dextran-free medium. Cells were fixed and 
observed with a confocal fluorescence microscope. 
 
Figure 4. Combined mutation of the tyrosine and dileucine motifs in p40-GFP. 48 h post-transfection 
with p40-GFP proteins harboring at least the dileucine substitution, combined to the mutation of one 
(double mutants: Y6A, Y106A or Y333A + LL360AV), or of the three tyrosine motifs (quadruple 
mutant: Y6A-Y106A-Y333A-LL360AV), cells were fixed and LAMP-1 was detected as described in 
figure 2. 
 
Figure 5. Analysis of the subcellular distribution of p40 and p40-GFP dileucine mutants, by 
fractionation on self-forming Percoll density gradients. HeLa cells were transfected with p40, p40-
GFP, p40 with the dileucine mutation (p40-LL360AV) or the dileucine mutant of p40-GFP (p40-
LL360AV-GFP). 48 h later, MLP fractions were prepared and fractionated on self-forming Percoll 
density gradients as described in Material and Methods. Seven fractions were collected and enzymatic 
activities of β–galactosidase () and alkaline phosphodiesterase () were measured to localise the 
lysosomes and the plasma membrane, respectively. Values on the graph represents the average 
percentage (+/- SD) of the enzymatic activity in each of the 7 fractions, calculated from all the 
experiments performed (n = 12). The open circles () represent the density of Percoll. The 
distributions of the late endosomal/lysosomal marker LAMP-1 and of the p40 proteins were analysed 
by Western blotting. Blots correspond to one representative experiment. 
 
Figure 6. Relative abundance of the p40 constructs at the plasma membrane in HeLa cells. A. 48 h 
post-transfection with p40-GFP constructs, HeLa cells were incubated on ice with a biotinylation 
reagent (Sulfo-NHS-S-S-Biotin), as described in Material and Methods. Biotinylated (Bound, B) 
proteins were separated from non-biotinylated ones (Unbound, U) by absorption on streptavidine 
agarose beads. Biotinylated proteins and one tenth of the non-biotinylated fraction were resolved by 
SDS-PAGE and the p40 proteins were detected by ECL-PlexTM Western blotting. Signals were 
quantified with the ImageQuantTM Software and the abundance of the biotinylated fraction relative to 
the total p40 proteins (Bound + Unbound signals) was calculated. Graph represents average values +/- 
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SD, with n ≥ 3. EEA1 was used as a negative control. B. HeLa cells transfected with the wild-type or 
the dileucine mutated forms (LL360AV) of p40, p40-HA or GFP-p40 were subjected to the cell 
surface biotinylation assay. Proteins were detected among the biotinylated and non-biotinylated 
fractions (1/10th) by Western blotting. Values on the histograms represent the percentage of the 
biotinylated signal relative to the total amount of p40 proteins (average +/- SD, n ≥ 3).      
 
Figure 7. Intracellular trafficking of p40 constructs. A. HeLa cells transiently transfected with a 
dominant negative construct of Eps15 tagged with GFP (GFP-EΔ95/295) were incubated 24h post-
transfection with Alexa 568-conjugated transferrin for 15 min at 37°C. After fixation with 4% 
paraformaldehyde and mounting in Mowiol, cells were observed by confocal fluorescent microscopy. 
B-C. HeLa cells were transiently cotransfected with a plasmid containing either wild-type-p40-HA (B) 
or p40-LL360AV-HA (C) together with the GFP-EΔ95/295 construct. Twenty-four hours post-
transfection, cells were fixed, permeabilised, and incubated with an anti-HA rabbit antibody followed 
by an Alexa 568-conjugated anti-rabbit secondary antibody. Arrows point to cells expressing GFP-
EΔ95/295 in which the uptake of transferrin was efficiently inhibited.  
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Figure 1 
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Figure 2A 
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Figure 2B 
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Figure 3A 
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Figure 3B 
 
 
 
 
 
 
 
 
 
Biochemical Journal Immediate Publication. Published on 14 May 2008 as manuscript BJ20071626
TH
IS
 IS
 N
O
T 
TH
E 
FI
NA
L 
VE
RS
IO
N 
- s
ee
 d
oi
:1
0.
10
42
/B
J2
00
71
62
6
St
ag
e 2
(a)
 PO
ST
-PR
INT
Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
© 2008 The Authors Journal compilation © 2008 Biochemical Society
 21 
Figure 4 
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Figure 5 
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Figure 6A 
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Figure 6B 
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Figure 7 
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